Biosurgical Agents | Market Insights | Europe | 2022
Procedure deferrals due to the COVID-19 pandemic severely impacted the European biosurgical agent market in 2020, and the elective nature of many postponed procedures will hinder the pace of recovery to some extent. However, as the situation improves, the European biosurgical agent market will grow modestly through the forecast period, driven by continuing growth in biosurgical procedures, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for laparoscopic devices in Europe across an 11-year period.
